Malaria in children. (Q52704614)

6 May 2018

title

Malaria in children. (English)

1 reference

6 May 2018

0 references

4

1 reference

6 May 2018

Cindy Chu

object named as

Cindy Chu

series ordinal

2

0 references

author name string

Jane Crawley

series ordinal

1

1 reference

6 May 2018

George Mtove

series ordinal

3

1 reference

6 May 2018

language of work or name

English

0 references

publication date

1 April 2010

1 reference

6 May 2018

published in

The Lancet

1 reference

6 May 2018

volume

375

1 reference

6 May 2018

issue

9724

1 reference

6 May 2018

page(s)

1468-1481

1 reference

6 May 2018

Epidemiology of congenital malaria in Nigeria: a multi-centre study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Malaria and blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Comparing methods of estimating the global morbidity burden from Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

A world malaria map: Plasmodium falciparum endemicity in 2007

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Marked increase in child survival after four years of intensive malaria control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Vivax malaria: a major cause of morbidity in early infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Vivax malaria: neglected and not benign

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Symptom overlap for malaria and pneumonia--policy implications for home management strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Undernutrition as an underlying cause of malaria morbidity and mortality in children less than five years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Indicators of life-threatening malaria in African children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The pathophysiology and treatment of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Severe malaria and concomitant bacteraemia in children admitted to a rural Mozambican hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Differentiating the pathologies of cerebral malaria by postmortem parasite counts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Electroencephalographic and clinical features of cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Pathogenesis, clinical features, and neurological outcome of cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Transfusion for respiratory distress in life-threatening childhood malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Hypoglycaemia in African children with severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Human malarial disease: a consequence of inflammatory cytokine release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The relevance of malaria pathophysiology to strategies of clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Plasmodium falciparum histidine-rich protein 1 associates with the band 3 binding domain of ankyrin in the infected red cell membrane.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Human cerebral malaria and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Diagnosis and management of the neurological complications of falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Dysregulation of coagulation in cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Perfusion abnormalities in children with cerebral malaria and malarial retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Retinal pathology of pediatric cerebral malaria in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The pathophysiology of falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Immunity to malaria: more questions than answers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Tumor necrosis factor ? in the pathogenesis of cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy con

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Low plasma concentrations of interleukin-10 in severe malarial anaemia compared with cerebral and uncomplicated malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Retention of erythrocytes in the spleen: a double-edged process in human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Is human malarial coma caused, or merely deepened, by sequestration?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Acidosis in severe childhood malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Severe malaria: lessons learned from the management of critical illness in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Malaria and fluids--balancing acts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Use of clinical algorithms for diagnosing malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Practical malaria tests promise results in remote regions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Artemisinin-based combination therapy for treating uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Hepatotoxicity Due to a Drug Interaction between Amodiaquine plus Artesunate and Efavirenz

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Intercontinental spread of pyrimethamine-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Artemisinin Resistance in Plasmodium falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Antimalarial dosing regimens and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Malaria treatment: no place like home

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Affordable medicines facility for malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Iron, infections, and anemia of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Iron supplementation in early childhood: health benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Intravenous Fluids — Getting the Balance Right

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Intrarectal quinine for treating Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Cost-effectiveness of artesunate for the treatment of severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Non-typhoidal salmonellae: a management challenge for children with community-acquired invasive disease in tropical African countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Blood transfusion for severe anaemia in children in a Kenyan hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Life-threatening severe malarial anaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Response to volume resuscitation in children with severe malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Cognitive impairment after cerebral malaria in children: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Cerebral malaria and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Routine anticonvulsants for treating cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The murine cerebral malaria phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Antipyretic measures for treating fever in malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Intermittent preventive treatment of malaria in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: A randomized, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Insecticide-treated bed nets and curtains for preventing malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Evolutionary and historical aspects of the burden of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Immunization of man against sporozite-induced falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Do we still need a malaria vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Flipping the paradigm on malaria transmission-blocking vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Initiative targets malaria eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

Human immunity and the design of multi-component, single target vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

A new global malaria eradication strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960447-3

7 January 2021

10.1016/S0140-6736(10)60447-3

Identifiers

DOI

1 reference

6 May 2018

PubMed ID

20417858

1 reference

6 May 2018